Reaction
Meningococcal Bacteraemia reporting signals
As of the last recalculation, Meningococcal Bacteraemia appears in 94 FAERS reports alongside 2 co-occurring drug terms. The strongest observed disproportionality signal is ECULIZUMAB (PRR 350.9).
Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
| Drug | Co-reports | PRR | ROR |
|---|---|---|---|
| Eculizumab | 45 | 350.9 | 351.2 |
| Ravulizumab | 5 | 86.5 | 86.5 |